New tentative approval for Teva Pharms drug dasatinib
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in […]
New tentative approval for Teva Pharms drug dasatinib Read Post »
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in […]
New tentative approval for Teva Pharms drug dasatinib Read Post »
Icosapent ethyl is the generic ingredient in two branded drugs marketed by Apotex, Dr Reddys, Hikma, Strides Pharma, Teva Pharms
New tentative approval for Ascent Pharms drug icosapent ethyl Read Post »
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in
New tentative approval for Teva Pharms drug dasatinib Read Post »
Icosapent ethyl is the generic ingredient in two branded drugs marketed by Apotex, Dr Reddys, Hikma, Strides Pharma, Teva Pharms
New tentative approval for Ascent Pharms drug icosapent ethyl Read Post »
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in
New tentative approval for Teva Pharms drug dasatinib Read Post »
Icosapent ethyl is the generic ingredient in two branded drugs marketed by Apotex, Dr Reddys, Hikma, Strides Pharma, Teva Pharms
New tentative approval for Ascent Pharms drug icosapent ethyl Read Post »
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in
New tentative approval for Teva Pharms drug dasatinib Read Post »
Icosapent ethyl is the generic ingredient in two branded drugs marketed by Apotex, Dr Reddys, Hikma, Strides Pharma, Teva Pharms
New tentative approval for Ascent Pharms drug icosapent ethyl Read Post »
Acetylcysteine is the generic ingredient in seven branded drugs marketed by Cumberland Pharms, Aspen, Eugia Pharma, Exela Pharma, Fresenius Kabi
New tentative approval for Rising drug acetylcysteine Read Post »
Get fresh news and insights, drug patent expirations & more…